Nexysbio

NexysBio is the service platform of Panthera Vax, LLC, offering an integrated suite of biotechnology services and products for drug discovery and development. The platform provides specialized capabilities across multiple disciplines, including vaccine antigen discovery, antibody engineering leveraging hybridoma and machine learning-guided design, and enzyme and protein engineering. Additionally, NexysBio offers multi-omics biomarker discovery, preclinical animal models for drug evaluation, and polymer nanoparticle drug formulation. To support these scientific workflows, the company also develops custom software solutions tailored for life sciences applications. By operating as a unified platform, NexysBio manages the entire research process, aiming to eliminate handoff delays and maintain consistent oversight across its service offerings. These capabilities are designed to assist researchers and organizations throughout the drug development lifecycle, from initial formulation and antigen validation to biomarker discovery and preclinical pharmacokinetic and pharmacodynamic evaluation. By providing a centralized infrastructure, the company enables partners to execute complex R&D programs through a single contract, ensuring integrated project management and technical execution.